QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
First Quantify Research Newsletter of 2014 published
2014-01-22
The first Quantify Research Newsletter of 2014 has been published.
Johan Mesterton published in Thrombosis Research
2014-01-22
The paper “Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry”, co-authored by Johan Mesterton, has been published in Thrombosis Research. Pubmed link
Fredrik Borgström and Gylfi Olafsson in The Spine Journal
The Spine Journal has published the paper “Real-life results of balloon kyphoplasty for vertebral compression fractures from the SWISSspine registry”, of which Quantify Research’s Fredrik Borgström and Gylfi Olafsson are co-authors. Pubmed link
Warm welcome to our new CEO Åsa By
Quantify Research would like to extend a warm welcome to our new CEO Åsa By. A full press release on the appointment of Åsa is available here.